Page 2 - ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு Today - Breaking & Trending Today

Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)

Press release content from Business Wire. The AP news staff was not involved in its creation.
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
January 25, 2021 GMT
CAMBRIDGE, United Kingdom (BUSINESS WIRE) Jan 25, 2021
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures. ....

United Kingdom , United States , Rowen Hughes , Samuel Cohen , Emer Reynolds , Lund University Sweden , Milken Institute , National Cancer Institute , Dartmouth College , Board Of Bausch Health , Baupost Group , Board Of Directors At Radius Health , Fidelity Investments Company , Celularity Inc , University Of Cambridge United Kingdom , Georgetown University , Radius Health , Clinical Development , Bausch Health , University Of Texas Md Anderson Cancer Center , National Institutes Of Health , Drug Administration , Bipartisan Policy Center , Samaritan Health Initiatives Inc , Eisai Co Ltd , Head Of Corporate Development At Intarcia Therapeutics ,

Syngene International's FY21 third-quarter PAT up 11%

Syngene International s FY21 third-quarter PAT up 11%
Syngene International s FY21 third-quarter PAT up 11%
21 January 2021 | News
The company posted quarterly revenue from operations of Rs 585 crore compared to Rs 519 crore in the corresponding quarter of last year
Source credit: Shutterstock
Syngene International Limited has announced its third-quarter FY21 results. The Company posted quarterly revenue from operations of Rs 585 crore compared to Rs 519 crore in the corresponding quarter of last year. EBITDA and PAT for the quarter were both up 11 per cent to Rs 193 crore and Rs 102 crore respectively.
Commenting on the results, Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International Ltd said, “We are pleased to report third-quarter growth in line with our guidance with revenue from operations growing 13 per cent while PAT was up 11 per cent. Sustained focus on employee and campus safety helped us maintain near-nor ....

Jonathan Hunt , Syngene International , Syngene International Ltd , Syngene International Limited , Managing Director , Chief Executive Officer , Deerfield Discovery , Q4fy21 Results , Integrated Drug Discovery , ஜொனாதன் வேட்டை , நிர்வகித்தல் இயக்குனர் , தலைமை நிர்வாகி அதிகாரி , தீர்ப்பியல்ட் கண்டுபிடிப்பு , ஒருங்கிணைந்த மருந்து கண்டுபிடிப்பு ,